ASX - By Stock
|
RGT |
Re:
Ann: $15M FINANCE FACILITY TO FUND REVENUE GROWTH FOR KEY MARKETS
|
|
Gbone9
|
101 |
32K |
2 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
101
|
32K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Phase II Clinical Trial on COVID-19 Patients Commenced
|
|
Gbone9
|
36 |
15K |
1 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
36
|
15K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Suspension from Official Quotation
|
|
Gbone9
|
70 |
26K |
5 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
70
|
26K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Gbone9
|
13 |
6.0K |
2 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
13
|
6.0K
|
2
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
Gbone9
|
11K |
8.7M |
2 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
11K
|
8.7M
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Clinical Trial Site Expansion into India
|
|
Gbone9
|
36 |
12K |
7 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
36
|
12K
|
7
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
Gbone9
|
11K |
8.7M |
2 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
11K
|
8.7M
|
2
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on commodity price
|
|
Gbone9
|
96 |
133K |
12 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
96
|
133K
|
12
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Gbone9
|
119 |
239K |
1 |
08/02/20 |
08/02/20 |
ASX - By Stock
|
119
|
239K
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
Gbone9
|
11K |
8.7M |
5 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
11K
|
8.7M
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Crosses 2,000 Prescription Milestone
|
|
Gbone9
|
36 |
21K |
12 |
09/01/20 |
09/01/20 |
ASX - By Stock
|
36
|
21K
|
12
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on S/P
|
|
Gbone9
|
16K |
11M |
2 |
08/01/20 |
08/01/20 |
ASX - By Stock
|
16K
|
11M
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Growth in Prescriptions Issued Continues During November
|
|
Gbone9
|
93 |
49K |
0 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
93
|
49K
|
0
|
|
ASX - By Stock
|
PLS |
Re:
PLS upside 2020 and beyond
|
|
Gbone9
|
344 |
231K |
3 |
13/12/19 |
13/12/19 |
ASX - By Stock
|
344
|
231K
|
3
|
|
Charts
|
PLS |
Re:
Turning upwards Fast
|
|
Gbone9
|
47 |
22K |
0 |
13/12/19 |
13/12/19 |
Charts
|
47
|
22K
|
0
|
|
ASX - By Stock
|
PLS |
Re:
Death Spiral
|
|
Gbone9
|
111 |
67K |
4 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
111
|
67K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
re:Lithium demand surge
|
|
Gbone9
|
3.0K |
1.7M |
1 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
3.0K
|
1.7M
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Approval Received for Distribution of CannEpil into Ireland
|
|
Gbone9
|
51 |
17K |
11 |
03/12/19 |
03/12/19 |
ASX - By Stock
|
51
|
17K
|
11
|
|
ASX - By Stock
|
PLS |
Re:
lithium pressure cooker
|
|
Gbone9
|
452 |
291K |
16 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
452
|
291K
|
16
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UK and Australia Roadshow Presentation
|
|
Gbone9
|
71 |
31K |
1 |
18/11/19 |
18/11/19 |
ASX - By Stock
|
71
|
31K
|
1
|
|
ASX - By Stock
|
VMT |
Re:
Flying
|
|
Gbone9
|
25 |
15K |
1 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
25
|
15K
|
1
|
|
ASX - By Stock
|
VMT |
Re:
Flying
|
|
Gbone9
|
25 |
15K |
0 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
25
|
15K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Reaches 1,000 Prescription Milestone Ahead of Schedule
|
|
Gbone9
|
81 |
29K |
7 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
81
|
29K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: 800 Prescription Milestone Passed for MGC Pharma Products
|
|
Gbone9
|
133 |
47K |
7 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
133
|
47K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: 800 Prescription Milestone Passed for MGC Pharma Products
|
|
Gbone9
|
133 |
47K |
6 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
133
|
47K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: 800 Prescription Milestone Passed for MGC Pharma Products
|
|
Gbone9
|
133 |
47K |
8 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
133
|
47K
|
8
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
Gbone9
|
11K |
8.7M |
12 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
11K
|
8.7M
|
12
|
|
ASX - By Stock
|
RGT |
Re:
Ann: 600 Prescription Milestone Passed for MGC Pharma Products
|
|
Gbone9
|
104 |
39K |
9 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
104
|
39K
|
9
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
Gbone9
|
11K |
8.7M |
7 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
11K
|
8.7M
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Passes 400 Prescription Milestone in September
|
|
Gbone9
|
104 |
33K |
4 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
104
|
33K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Passes 400 Prescription Milestone in September
|
|
Gbone9
|
104 |
33K |
4 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
104
|
33K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
Cause for concern?
|
|
Gbone9
|
10 |
7.3K |
5 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
10
|
7.3K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: 200 Prescription Milestone Passed in Australia & UK
|
|
Gbone9
|
31 |
10K |
1 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
31
|
10K
|
1
|
|
ASX - By Stock
|
PLS |
Re:
re:Lithium demand surge
|
|
Gbone9
|
3.0K |
1.7M |
1 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
3.0K
|
1.7M
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Financial Report for 30 June 2019
|
|
Gbone9
|
365 |
254K |
0 |
23/08/19 |
23/08/19 |
ASX - By Stock
|
365
|
254K
|
0
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on S/P
|
|
Gbone9
|
16K |
11M |
6 |
02/08/19 |
02/08/19 |
ASX - By Stock
|
16K
|
11M
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: June Quarterly Activity and Cashflow Report
|
|
Gbone9
|
32 |
15K |
1 |
11/07/19 |
11/07/19 |
ASX - By Stock
|
32
|
15K
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Great Wall Spinoff Plans 5 Cobalt Free Lithium Battery Factories Worldwide
|
|
Gbone9
|
16 |
7.0K |
3 |
10/07/19 |
10/07/19 |
ASX - By Stock
|
16
|
7.0K
|
3
|
|
ASX - By Stock
|
PLS |
Re:
re:Lithium demand surge
|
|
Gbone9
|
3.0K |
1.7M |
20 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
3.0K
|
1.7M
|
20
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on S/P
|
|
Gbone9
|
16K |
11M |
2 |
28/06/19 |
28/06/19 |
ASX - By Stock
|
16K
|
11M
|
2
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on S/P
|
|
Gbone9
|
16K |
11M |
6 |
25/06/19 |
25/06/19 |
ASX - By Stock
|
16K
|
11M
|
6
|
|
ASX - By Stock
|
PLS |
Re:
PLS price end of this year
|
|
Gbone9
|
361 |
177K |
7 |
19/06/19 |
19/06/19 |
ASX - By Stock
|
361
|
177K
|
7
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on S/P
|
|
Gbone9
|
16K |
11M |
3 |
19/06/19 |
19/06/19 |
ASX - By Stock
|
16K
|
11M
|
3
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Production and Sales Update
|
|
Gbone9
|
314 |
197K |
7 |
17/06/19 |
17/06/19 |
ASX - By Stock
|
314
|
197K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Pharma Update - Increased Orders and Clinical Study
|
|
Gbone9
|
51 |
16K |
0 |
13/06/19 |
13/06/19 |
ASX - By Stock
|
51
|
16K
|
0
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on S/P
|
|
Gbone9
|
16K |
11M |
3 |
12/06/19 |
12/06/19 |
ASX - By Stock
|
16K
|
11M
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Gbone9
|
63 |
34K |
0 |
03/06/19 |
03/06/19 |
ASX - By Stock
|
63
|
34K
|
0
|
|
ASX - By Stock
|
PLS |
Re:
Day to day discussions on S/P
|
|
Gbone9
|
16K |
11M |
0 |
07/05/19 |
07/05/19 |
ASX - By Stock
|
16K
|
11M
|
0
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Corporate Presentation
|
|
Gbone9
|
46 |
28K |
5 |
01/05/19 |
01/05/19 |
ASX - By Stock
|
46
|
28K
|
5
|
|
Charts
|
PLS |
Re:
PLS chart to start 2019
|
|
Gbone9
|
2.4K |
1.4M |
2 |
30/04/19 |
30/04/19 |
Charts
|
2.4K
|
1.4M
|
2
|
|